Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 2024-05, Vol.248, p.109894-109894, Article 109894
Hauptverfasser: Teema, Asmaa M., Zaitone, Sawsan A., Moustafa, Yasser M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109894
container_issue
container_start_page 109894
container_title Neuropharmacology
container_volume 248
creator Teema, Asmaa M.
Zaitone, Sawsan A.
Moustafa, Yasser M.
description
doi_str_mv 10.1016/j.neuropharm.2024.109894
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2938285146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390824000637</els_id><sourcerecordid>2938285146</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1646-591ebff1d3049b8eb3e2236a09671a272e4da60ac8bc52bbfa654ff4252e48873</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxiMEoqXwCmiORSKL7ThZhxtU_FmpKgjBCaHIcSa7XhI7tZPSvfUduMLL9QV4BSZsKUdOtsbffJ75fkkCnC0448Wz7cLhFPyw0aFfCCYklUtVyjvJIVfLLF2yQt5NDhkTKs1Kpg6SBzFuGWNScXU_OciUlJkQxWHy6wOOQZvRegdnfrQGYfRwffVjVU9D8C068AEGG_ylNboHqo1oxgjOroPu4M8cLoJ2DTTY6V2EcYN0vcDODz26EXwLXdr4QYN1zWSQhLv41TqMdi5B0GT3zY4bwMsBg52byPm9DiSK3tnYP4eVa7sJHY1Hg2q3tn6Ns0O8vvoJn89u09DGd369e0pRLeFYUFhPgFaljb6DzNmXh8m9VncRH92cR8mn168-nrxNT9-9WZ28OE0NL2SR5iXHum15kzFZ1grrDIXICs3KYsm1WAqUjS6YNqo2uajrVhe5bFspcnpRhOAoOd77UmDnE8ax6m002HXaoZ9iJcpMCZVzWZBU7aUm-BgDttVAIeiwqzirZtzVtvqHu5pxV3vc1Pr45pep7rG5bfzLlwQv9wKkXS8shioaO8fY2EAYq8bb___yG3Fhx_Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2938285146</pqid></control><display><type>article</type><title>Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]</title><source>Access via ScienceDirect (Elsevier)</source><creator>Teema, Asmaa M. ; Zaitone, Sawsan A. ; Moustafa, Yasser M.</creator><creatorcontrib>Teema, Asmaa M. ; Zaitone, Sawsan A. ; Moustafa, Yasser M.</creatorcontrib><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2024.109894</identifier><identifier>PMID: 38443226</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Neuropharmacology, 2024-05, Vol.248, p.109894-109894, Article 109894</ispartof><rights>2024 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuropharm.2024.109894$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38443226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teema, Asmaa M.</creatorcontrib><creatorcontrib>Zaitone, Sawsan A.</creatorcontrib><creatorcontrib>Moustafa, Yasser M.</creatorcontrib><title>Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkc9u1DAQxiMEoqXwCmiORSKL7ThZhxtU_FmpKgjBCaHIcSa7XhI7tZPSvfUduMLL9QV4BSZsKUdOtsbffJ75fkkCnC0448Wz7cLhFPyw0aFfCCYklUtVyjvJIVfLLF2yQt5NDhkTKs1Kpg6SBzFuGWNScXU_OciUlJkQxWHy6wOOQZvRegdnfrQGYfRwffVjVU9D8C068AEGG_ylNboHqo1oxgjOroPu4M8cLoJ2DTTY6V2EcYN0vcDODz26EXwLXdr4QYN1zWSQhLv41TqMdi5B0GT3zY4bwMsBg52byPm9DiSK3tnYP4eVa7sJHY1Hg2q3tn6Ns0O8vvoJn89u09DGd369e0pRLeFYUFhPgFaljb6DzNmXh8m9VncRH92cR8mn168-nrxNT9-9WZ28OE0NL2SR5iXHum15kzFZ1grrDIXICs3KYsm1WAqUjS6YNqo2uajrVhe5bFspcnpRhOAoOd77UmDnE8ax6m002HXaoZ9iJcpMCZVzWZBU7aUm-BgDttVAIeiwqzirZtzVtvqHu5pxV3vc1Pr45pep7rG5bfzLlwQv9wKkXS8shioaO8fY2EAYq8bb___yG3Fhx_Y</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Teema, Asmaa M.</creator><creator>Zaitone, Sawsan A.</creator><creator>Moustafa, Yasser M.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]</title><author>Teema, Asmaa M. ; Zaitone, Sawsan A. ; Moustafa, Yasser M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1646-591ebff1d3049b8eb3e2236a09671a272e4da60ac8bc52bbfa654ff4252e48873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teema, Asmaa M.</creatorcontrib><creatorcontrib>Zaitone, Sawsan A.</creatorcontrib><creatorcontrib>Moustafa, Yasser M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teema, Asmaa M.</au><au>Zaitone, Sawsan A.</au><au>Moustafa, Yasser M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>248</volume><spage>109894</spage><epage>109894</epage><pages>109894-109894</pages><artnum>109894</artnum><issn>0028-3908</issn><eissn>1873-7064</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38443226</pmid><doi>10.1016/j.neuropharm.2024.109894</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2024-05, Vol.248, p.109894-109894, Article 109894
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_2938285146
source Access via ScienceDirect (Elsevier)
title Retraction Notice to “Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis” [Neuropharmacology, 107 (2016) 432 – 450]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A10%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retraction%20Notice%20to%20%E2%80%9CIbuprofen%20or%20piroxicam%20protects%20nigral%20neurons%20and%20delays%20the%20development%20of%20l-dopa%20induced%20dyskinesia%20in%20rats%20with%20experimental%20Parkinsonism:%20Influence%20on%20angiogenesis%E2%80%9D%20%5BNeuropharmacology,%20107%20(2016)%20432%20%E2%80%93%20450%5D&rft.jtitle=Neuropharmacology&rft.au=Teema,%20Asmaa%20M.&rft.date=2024-05-01&rft.volume=248&rft.spage=109894&rft.epage=109894&rft.pages=109894-109894&rft.artnum=109894&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2024.109894&rft_dat=%3Cproquest_cross%3E2938285146%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2938285146&rft_id=info:pmid/38443226&rft_els_id=S0028390824000637&rfr_iscdi=true